Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8976 |
High Similarity |
NPD1091 |
Approved |
0.8741 |
High Similarity |
NPD1653 |
Approved |
0.8529 |
High Similarity |
NPD1613 |
Approved |
0.8529 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8175 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8169 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8162 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8056 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8038 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7987 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7987 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7862 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7761 |
Intermediate Similarity |
NPD1357 |
Approved |
0.773 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.773 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7721 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7656 |
Intermediate Similarity |
NPD290 |
Approved |
0.7643 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD7228 |
Approved |
0.758 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD228 |
Approved |
0.7548 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7532 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7465 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7464 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7463 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7438 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7436 |
Intermediate Similarity |
NPD37 |
Approved |
0.7426 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7405 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7405 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7405 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7389 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7292 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7266 |
Intermediate Similarity |
NPD291 |
Approved |
0.7255 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7246 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7239 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7234 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7206 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7197 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7178 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD968 |
Approved |
0.717 |
Intermediate Similarity |
NPD2978 |
Approved |
0.717 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7163 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD8313 |
Approved |
0.716 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7143 |
Intermediate Similarity |
NPD556 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7125 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7124 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7095 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7086 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7081 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7071 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7067 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7067 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7051 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7047 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7042 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.6994 |
Remote Similarity |
NPD6841 |
Approved |
0.6994 |
Remote Similarity |
NPD6842 |
Approved |
0.6994 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.698 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6972 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6966 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6962 |
Remote Similarity |
NPD3686 |
Approved |
0.6962 |
Remote Similarity |
NPD3687 |
Approved |
0.6954 |
Remote Similarity |
NPD7033 |
Discontinued |
0.695 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.695 |
Remote Similarity |
NPD5126 |
Approved |
0.6944 |
Remote Similarity |
NPD3225 |
Approved |
0.6928 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6899 |
Remote Similarity |
NPD5403 |
Approved |
0.6892 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6892 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6883 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6883 |
Remote Similarity |
NPD3060 |
Approved |
0.6883 |
Remote Similarity |
NPD4237 |
Approved |
0.6879 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD4123 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD4675 |
Approved |
0.6875 |
Remote Similarity |
NPD4678 |
Approved |
0.6863 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6852 |
Remote Similarity |
NPD5772 |
Approved |
0.6852 |
Remote Similarity |
NPD5773 |
Approved |
0.6846 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6846 |
Remote Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6833 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6831 |
Remote Similarity |
NPD5846 |
Approved |
0.6831 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6829 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6828 |
Remote Similarity |
NPD6696 |
Suspended |
0.6813 |
Remote Similarity |
NPD3111 |
Phase 1 |
0.681 |
Remote Similarity |
NPD2560 |
Approved |
0.681 |
Remote Similarity |
NPD2563 |
Approved |
0.6797 |
Remote Similarity |
NPD6099 |
Approved |
0.6797 |
Remote Similarity |
NPD9296 |
Approved |
0.6797 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6797 |
Remote Similarity |
NPD6100 |
Approved |
0.6797 |
Remote Similarity |
NPD6032 |
Approved |
0.6792 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6786 |
Remote Similarity |
NPD27 |
Approved |
0.6786 |
Remote Similarity |
NPD2489 |
Approved |
0.6779 |
Remote Similarity |
NPD1048 |
Approved |
0.6776 |
Remote Similarity |
NPD7680 |
Approved |
0.6774 |
Remote Similarity |
NPD4162 |
Approved |
0.6774 |
Remote Similarity |
NPD5062 |
Approved |
0.6774 |
Remote Similarity |
NPD5061 |
Approved |
0.6772 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6772 |
Remote Similarity |
NPD5401 |
Approved |
0.6766 |
Remote Similarity |
NPD6071 |
Discontinued |
0.6765 |
Remote Similarity |
NPD3022 |
Approved |
0.6765 |
Remote Similarity |
NPD3021 |
Approved |
0.6759 |
Remote Similarity |
NPD3685 |
Discontinued |
0.6755 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6755 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6755 |
Remote Similarity |
NPD5735 |
Approved |
0.6755 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6753 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6753 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6753 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6753 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6752 |
Remote Similarity |
NPD3122 |
Phase 3 |
0.6747 |
Remote Similarity |
NPD5494 |
Approved |
0.6743 |
Remote Similarity |
NPD4663 |
Approved |
0.6738 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6735 |
Remote Similarity |
NPD558 |
Phase 2 |
0.6735 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6733 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.6732 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6731 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6731 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6731 |
Remote Similarity |
NPD3892 |
Phase 2 |
0.6731 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6731 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6726 |
Remote Similarity |
NPD2969 |
Approved |
0.6726 |
Remote Similarity |
NPD2970 |
Approved |
0.6712 |
Remote Similarity |
NPD2922 |
Phase 1 |
0.6711
|
Remote Similarity |
NPD3179 |
Approved |